Holen Sie sich die Stockscreener-App
224.40
1.23%
2.63
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$221.77
Offen:
$223.73
24-Stunden-Volumen:
840.06K
Relative Volume:
0.40
Marktkapitalisierung:
$52.57B
Einnahmen:
$250.74B
Nettoeinkommen (Verlust:
$1.55B
KGV:
34.31
EPS:
6.5398
Netto-Cashflow:
$4.39B
1W Leistung:
-0.84%
1M Leistung:
+11.87%
6M Leistung:
+9.40%
1J Leistung:
+37.39%
1-Tages-Spanne:
$222.43
$228.45
1-Wochen-Bereich:
$219.47
$229.78
52-Wochen-Spanne:
$137.75
$233.60
Cardinal Health Inc Stock (CAH) Company Profile
Firmenname
Cardinal Health Inc
Sektor
Branche
Telefon
(614) 757-3033
Adresse
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH vs MCK, COR, HSIC, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
224.48 | 51.94B | 250.74B | 1.55B | 4.39B | 6.5398 |
MCK
Mckesson Corp
|
749.04 | 87.88B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
272.19 | 52.89B | 328.68B | 2.55B | 1.56B | 13.03 |
HSIC
Henry Schein Inc
|
79.45 | 9.10B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.3005 | 1.15B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-06-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Hochstufung | Jefferies | Hold → Buy |
| 2025-01-08 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-12-13 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Fortgesetzt | Mizuho | Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Hochstufung | Argus | Hold → Buy |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Underweight |
| 2023-07-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Eingeleitet | Citigroup | Neutral |
| 2023-02-03 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-05-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-08-06 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-05-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-05-15 | Hochstufung | UBS | Neutral → Buy |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-03-20 | Hochstufung | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-27 | Herabstufung | Argus | Buy → Hold |
| 2019-08-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-04-18 | Eingeleitet | Guggenheim | Neutral |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2018-11-16 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Hochstufung | Argus | Hold → Buy |
| 2018-03-08 | Eingeleitet | Barclays | Equal Weight |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Underperform |
| 2018-01-05 | Eingeleitet | Evercore ISI | In-line |
Alle ansehen
Cardinal Health Inc Aktie (CAH) Neueste Nachrichten
Cardinal Health Stockweekly outlook with sector review - AD HOC NEWS
Cardinal Health (CAH) Stock Could Be 9.6% Undervalued Despite Rich P/E Signals - Yahoo Finance
Cardinal Health stock: Is CAH outperforming the healthcare sector? - MSN
Why Cardinal Health Monoject syringes quietly matter on busy wards - AD HOC NEWS
CAH Stock Up Nearly 8% YTD: Will the Uptrend Continue in the Rest of 2026? - TradingView
Smart logistics in the hospital, Cardinal Health Pyxis™ Logistics keeps trays flowing - AD HOC NEWS
Cardinal Health Inc (CAH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cardinal Health (CAH) stock declines while market improves: Some information for investors - MSN
Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Cardinal Health Inc. stock underperforms Thursday when compared to competitors - MarketWatch
COR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell? - TradingView
Cardinal Health is one of the S&P 500’s biggest decliners today. A guidance hike didn’t matter. - MSN
Cardinal Health Inc (CAH) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cardinal Health Inc (CAH) Institutional Confidence - TradingKey
Cardinal Health Inc (CAH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cardinal Health Inc (CAH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cardinal Health Inc (CAH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cardinal Health (CAH) Gets a Buy from William O’Neil - The Globe and Mail
Cardinal Health (CAH) Stock Could Be 7.2% Undervalued After Guidance Raise - Sahm
Cardinal Health Stock Rockets 11% With 5-Day Winning Streak - Trefis
Cardinal Health Inc. stock rises Monday, still underperforms market - MarketWatch
Cardinal Health options trading jumps with focus on puts By Investing.com - Investing.com Nigeria
Cardinal Health options trading jumps with focus on puts - Investing.com
Cardinal Health Stock: Is CAH Outperforming the Healthcare Sector? - Barchart.com
Top 3 Health Care Stocks That May Collapse This Quarter - Benzinga
Cardinal Health, Inc. (CAH) - DirectorsTalk Interviews
Cardinal Health Inc. Stock (US14149Y1082): Insider and institutional ownership moves in focus - AD HOC NEWS
Cardinal Health Inc. Stock (US14149Y1082): Ownership shift puts hospital-at-home strategy in focus - AD HOC NEWS
Cardinal Health (CAH) Edges Higher as Healthcare Distribution Giant Hests Above Key SupportPCR Extreme - newsline.com
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Cardinal Health Inc. Stock (US14149Y1082): Valuation in focus after recent gains - AD HOC NEWS
Is Cardinal Health (CAH) Stock Undervalued Right Now? - Yahoo Finance
William O'Neil Initiates Cardinal Health at Buy - Moomoo
Cardinal Health Inc. Stock (US14149Y1082): valuation focus as shares hover near recent highs - AD HOC NEWS
Barclays Keeps Their Buy Rating on Cardinal Health (CAH) - The Globe and Mail
Cardinal Health Stock: Does It Diversify Your Portfolio Or Just Double Down On Market Risk? - Trefis
Elinor Riggs Joins Cardinal Health as SVP, CIO & CTO, Pharmaceutical & Specialty Solutions - hrtoday.in
Barclays Maintains Cardinal Health(CAH.US) With Buy Rating, Maintains Target Price $258 - Moomoo
Cardinal Health Inc. (CAH) Q1 2026 Earnings: Strong EPS Beat Drives Stock HigherDividend Increase Stocks - newsline.com
Is Cardinal Health Inc (CAH) Overvalued After 4.0% Rally? GF Val - GuruFocus
Cardinal Health Inc. stock (US14149Y1082): shares consolidate after strong Q3 earnings beat - AD HOC NEWS
[144] CARDINAL HEALTH INC SEC Filing - Stock Titan
[Latest] Surgical Masks Market Size Will Attain USD 6.76 Billion by 2034 Registering a Promising CAGR of 5.5% - GlobeNewswire Inc.
Cardinal Health, Inc. (CAH) Stock Analysis: Strong Buy Ratings And A 19% Potential Upside - DirectorsTalk Interviews
Why Is Cardinal Health Expanding Beyond Traditional Healthcare Distribution? - Kalkine Media
Do options traders know something about Cardinal Health stock we don't? - MSN
Cardinal Health, Inc. Trade Ideas — XETR:CLH - TradingView
Enterprise value of Cardinal Health, Inc. – XETR:CLH - TradingView
Total debt per share of Cardinal Health, Inc. – XETR:CLH - TradingView
ETFs Investing in Cardinal Health, Inc. Stocks - TradingView
Richard C. Witzel Jr. - Crain's Chicago Business
Finanzdaten der Cardinal Health Inc-Aktie (CAH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.18%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):